Diabetic neuropathy, a debilitating complication of diabetes, affects millions of patients, causing chronic nerve pain and significantly diminishing their quality of life. Dr. Michael Fishman, a leader in pain management, champions Spinal Cord Stimulation (SCS) as a proven and effective treatment for patients suffering from diabetic peripheral neuropathy (DPN). At his practice, Dr. Fishman utilizes advanced technology now offering patients Inceptiv SCS, an innovative FDA-approved approach to pain relief that is both non-invasive and long-lasting.
Understanding Diabetic Neuropathy Symptoms
Diabetic peripheral neuropathy occurs when prolonged high blood sugar levels damage the nerves, most commonly in the feet and legs. Patients often experience a range of symptoms, including:
- Numbness or tingling in the extremities
- Burning or sharp pain
- Heightened sensitivity to touch
- Muscle weakness
- Difficulty with balance or coordination
As DPN progresses, these symptoms can become severe, leading to ulcers, infections, or even the risk of amputation.
Dr. Fishman Champions Spinal Cord Stimulation for Relief
Dr. Michael Fishman strongly supports Spinal Cord Stimulation (SCS), a minimally invasive procedure that uses electrical impulses to block pain signals from reaching the brain. In his practice, Dr. Fishman uses Inceptiv’s advanced SCS technology, which includes diabetic foot pain associated with DPN as one condition for which SCS might be an option.
An FDA-Approved Treatment for Lasting Pain Relief
Inceptiv SCS therapy is an FDA-approved treatment option for DPN pain that disrupts pain signals, providing an effective alternative for patients who have struggled with other treatment methods. The implantable device may be an ideal fit for individuals who:
- Experience pain in the legs or feet
- Have had DPN pain for at least a year
- Have not had success managing DPN pain with their current treatment
- Have DPN pain that negatively impacts sleep and quality of life
By contrast to the traditional suboptimal therapy experiences, Inceptiv SCS senses biological signals and consistently maintains the physician’s prescribed stimulation that is tailored to a patient’s needs. Inceptiv also offers unparalleled access to diagnostic imaging, with 1.5T and 3T full-body MRI access with no power or impedance restrictions.
SCS therapy has been shown to reduce pain by 50% or more in over 60% of patients suffering from painful diabetic neuropathy, according to clinical studies published in Diabetes Care. Dr. Fishman emphasizes that SCS not only reduces pain but also improves patients’ mobility, sleep, and overall quality of life.
For more information about Dr. Fishman’s approach to diabetic neuropathy treatment, view this informative video: Watch Here.
A New Era of Pain Management
Dr. Fishman’s practice is at the forefront of pain management, offering patients a comprehensive approach to treating diabetic neuropathy. As a champion of Spinal Cord Stimulation, he provides consultations and administers this life-changing Inceptiv therapy to those in need. His goal is to empower patients with advanced treatments that help them reclaim their lives from chronic pain.
For more information or to schedule a consultation with Dr. Michael Fishman regarding SCS therapy, please contact 717-273-6706 x1145 or visit doctorfishman.com.